Lucira Health Inc logo

LHDX - Lucira Health Inc Share Price

$7.1 0.0  0.6%

Last Trade - 22/04/21

Small Cap
Market Cap £195.3m
Enterprise Value £144.8m
Revenue £n/a
Position in Universe 4237th / 6851
Unlock LHDX Revenue
Relative Strength (%)
1m -55.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -81.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 111.5
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, LuciraHealth Inc revenues was not reported. Net loss increasedfrom $6.4M to $20.2M. Higher net loss reflects Research anddevelopment - Balancing val increase of 86% to $16M(expense), Grant income decrease of 56% to $2M (income),Remeasurement of derivative liabilities increase from $240Kto $2.8M (expense). Basic Earnings per Share excludingExtraordinary Items decreased from -$0.17 to -$0.55.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


LHDX Revenue Unlock LHDX Revenue

Net Income

LHDX Net Income Unlock LHDX Revenue

Normalised EPS

LHDX Normalised EPS Unlock LHDX Revenue

PE Ratio Range

LHDX PE Ratio Range Unlock LHDX Revenue

Dividend Yield Range

LHDX Dividend Yield Range Unlock LHDX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
LHDX EPS Forecasts Unlock LHDX Revenue
Profile Summary

Lucira Health, Inc. is medical technology company. The Company is focused on the development and commercialization of transformative and infectious disease test kits. The Company has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and test kit that is powered by two AA batteries and fit in the palm of a hand. Its initial focus is within respiratory diseases, starting with COVID-19 and influenza A and B virus indications. It has developed LUCIRA COVID-19 All-In-One Test Kit (COVID-19 test kit), is a single-use, molecular in vitro diagnostic test that has an analytical sensitivity to detect the SARS-CoV-2 virus. The test is authorized for prescription at-home use.

Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated February 20, 2013
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 38,534,923
Free Float (0.0%)
Eligible for
LHDX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for LHDX
Upcoming Events for LHDX
Thursday 13th May, 2021
Q1 2021 Lucira Health Inc Earnings Release
Frequently Asked Questions for Lucira Health Inc
What is the Lucira Health Inc share price?

As of 22/04/21, shares in Lucira Health Inc are trading at $7.1, giving the company a market capitalisation of £195.3m. This share price information is delayed by 15 minutes.

How has the Lucira Health Inc share price performed this year?

Shares in Lucira Health Inc are currently trading at $7.1 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lucira Health Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Lucira Health Inc?

There are no analysts currently covering Lucira Health Inc.

When will Lucira Health Inc next release its financial results?

Lucira Health Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Lucira Health Inc dividend yield?

Lucira Health Inc does not currently pay a dividend.

Does Lucira Health Inc pay a dividend?

Lucira Health Inc does not currently pay a dividend.

When does Lucira Health Inc next pay dividends?

Lucira Health Inc does not currently pay a dividend.

How do I buy Lucira Health Inc shares?

To buy shares in Lucira Health Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lucira Health Inc?

Shares in Lucira Health Inc are currently trading at $7.1, giving the company a market capitalisation of £195.3m.

Where are Lucira Health Inc shares listed? Where are Lucira Health Inc shares listed?

Here are the trading details for Lucira Health Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: LHDX
What kind of share is Lucira Health Inc?

Based on an overall assessment of its quality, value and momentum, Lucira Health Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Lucira Health Inc share price forecast 2021?

Shares in Lucira Health Inc are currently priced at $7.1. At that level they are trading at 0.169% discount to the analyst consensus target price of 0.00.

How can I tell whether the Lucira Health Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lucira Health Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $7.1, shares in Lucira Health Inc are trading at -58.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lucira Health Inc PE Ratio?

We were not able to find PE ratio data for Lucira Health Inc.

Who are the key directors of Lucira Health Inc?

We were unable to find the directors for Lucira Health Inc.

Who are the major shareholders of Lucira Health Inc?

Here are the top five shareholders of Lucira Health Inc based on the size of their shareholding:

EPIQ Capital Group, LLC Investment Advisor
Percentage owned: 34.06% (13.1m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 2.89% (1.12m shares)
American Funds SMALLCAP World Fund Mutual Fund
Percentage owned: 2.32% (892k shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.55% (597k shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 1.14% (439k shares)
Similar to LHDX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.